Alliance for Patient Access
Based in IA
AI Overview
With $680K in lobbying spend across 29 quarterly filings, Alliance for Patient Access is an active lobbying client. Their lobbying covers 1 issue area. Active from 2019 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $90K |
| 2020 | $120K |
| 2021 | $150K |
| 2022 | $80K |
| 2023 | $80K |
| 2024 | $80K |
| 2025 | $80K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Alliance for Patient Access disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Issues impacting patient access to care and treatment options
Clinical Trials barriers (cost)
HR 2279 -To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a pla
Clinical Trials barriers (cost)
HR 2279/ S 2546 - To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with
PL 116-136 - Coronavirus Aid, Relief, and Economic Security Act or the CARES Act - support for telehealth expansion, Part B home infusion expansion, limits on copays, support for CMS waiver authority
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.